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Abstract
Introduction: Migraine is considered to be a multifactorial, complex disease.
Various genetic and environmental factors contribute to the manifestation of
this disease. The aim of this study was to determine whether polymorphisms
in the tumour necrosis factor (TNF) region are associated with the risk of
migraine. We examined the association between 6 single nucleotide
polymorphisms in the coding regions of TNF-α and TNF-β genes and migraine.
Material and methods: The study included two groups of children (group A and
group B). Group A consisted of 103 unrelated children with typical migraine
without aura 5-14 years of age. Group B (control group) consisted of 178
unrelated healthy children. The diagnosis of migraine was, in all patients, made
according to the International Classification of Headache Disorders (ICHD II).
Results: According to our results positive family history was present in 62.2%
of patients of group A. No significant differences were found in the frequencies
of genotypes or alleles between patients and controls. The non-parametric
analyses of variance showed no significant differences in the age at onset
between genotype groups of the TNF-α and TNF-β gene polymorphisms.
Comparison of genotype frequencies between boys and girls in affected patients
and control individuals were not significantly different (p = 0.089, p =0.073
respectively). The distribution of TNF polymorphisms was not associated with
the presence of family history of migraine in patients.
Conclusions: Our data indicate that TNF-α and TNF-β gene polymorphisms are
not a significant risk factor for migraine without aura in Greek children.
Key words: migraine, tumour necrosis factor α, tumour necrosis factor β,
polymorphism, children.
Introduction
Migraine is a multifactorial, complex disease. The aetiology of a migraine
attack is only partly understood [1]. It is considered that various genetic
and environmental factors contribute to the manifestation of this disease
[2, 3]. The mode of transmission of migraine in families is still unclear since
migraine does not fit a simple Mendelian pattern.
The type and the number of genes which link to migraine are still
unclear [4]. An increased knowledge of the genetic risk factors as well as
an understanding of the underlying pathogenesis is expected to enable
clinicians to identify children at a high risk and to treat childhood migraine
more effectively [4].
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Many of the genetic factors, such as the TNF
gene, the calcium channel gene CACNAIA, and the
ednra gene, which have to date been shown to be
linked to adult migraine susceptibility have also
been investigated in children [5, 6]. Polymorphisms
in several candidate genes have been proposed
either as susceptibility markers or as useful tools
for the dissection of the related phenotypes [5-7].
The pathophysiology of migraine is still unknown,
although “sterile inflammation” or “neurogenic
inflammation” seems to play a key role [8].
Tumour necrosis factor (TNF) is a cytokine
implicated in inflammatory reactions and endo  -
thelial function. There is considerable evidence for
a major role of TNF in initiating inflammatory
hyperalgesia [10-12].
Tumour necrosis factor can promote powerful
hyperalgesia by causing prostanoid release,
increasing the expression of bradykinin receptors
or by modulation of activity within sympathetic
fibres. Increased levels of TNF-α in migraineurs have
been documented; therefore, it may be involved in
migraine [13]. Also, TNF-α is a possible pain
mediator in neurovascular inflammation. Therefore
it might be a potential mechanism for the
generation of migraine pain. Rainero et al. [14] have
reported that homozygosity for the G allele in 
TNF-α-308 was associated with an increased risk
of migraine in an Italian population. However,
previous studies concerning the role of TNF-α in
migraine have provided conflicting results and there
has been no confirmation of the role of TNF-α-308
markers in migraine patients [10, 14-16].
The aim of this study was to determine whether
polymorphisms in the TNF region are associated
with the risk of migraine. Therefore we examined
the association between 6 single nucleotide
polymorphisms in the coding regions of TNF-α and
TNF-β genes and migraine in Greek children. 
Material and methods 
The study included two groups of children
(group A and group B). Group A consisted of 103
unrelated children with typical migraine without
aura 5-14 years of age (mean age ± SE = 10.5 ±0.7),
46 boys (44.7%) and 57 girls (55.3%). All children
of group A were attending the paediatric headache
outpatient clinic of the 2nd Department of
Paediatrics of the Medical School of Aristotle
University of Thessaloniki. The diagnosis of
migraine was, in all patients, made according to
the International Classification of Headache
Disorders (ICHD II) by a neurologist specialized in
paediatric headaches, while a family history
concerning the presence of migraine attacks in
parents and siblings was obtained from the
parents themselves, through an interview by
specialized personnel [17]. The patient underwent
an extensive physical and neurological exa  -
mination. Positive family history was present in
82% of patients of group A.
Group B (control group) consisted of 178
unrelated healthy children, 75 boys (42.1%) and 103
girls (57.9%), the age range (mean age ± SE 
= 12.2 ±1.7). The healthy children (used as controls)
consisted of individuals whose parents were
interviewed and indicated in a questionnaire that
they had never suffered from migraine or any
similar condition and that the same was true of
their first and second degree relatives. Patients and
controls originated from the same geographical
region (northern Greece) and were recruited in
parallel, at a similar time and geographical location
as the case group, to avoid the potential bias of
population stratification. The mean age of the
control group was, in an attempt to exclude
subjects with late-onset migraine, purposely higher
than the age of the patients. Written informed
consent was obtained from all parents of the
participants. This research was approved by the
Local Ethics Committee. 
Genetic analysis
Genomic DNA was isolated from whole
peripheral blood according to the protocol of the
manufacturer (Pure gene, DNA purification system,
Gentra). The analysis of DNA samples was
performed by the PCR-RFLPs method. Six single
nucleotide polymorphisms (SNPs) in TNF genes
(TNF-α-238 G/A, TNF-α-308G/A, TNF-α-1031T/C, 
TNF-α-857C/T, TNF-α-376G/A, and TNF-β-252 A/G)
were genotyped by the PCR restriction fragment
length polymorphism (RFLP) method. 
Genotyping
The forward primer sequence and the reverse
sequence of all 6 SNPs are shown in Table I. In 
Table II are shown the restriction enzyme, the PCR
product and digest fragment (bp) after the action
of the restriction enzyme of all 6 polymorphisms.
Statistical analysis
Hardy-Weinberg equilibrium (HWE) of alleles at
individual  loci  and comparison of genotype
frequencies between cases and controls were
assessed by χ2 statistics.
Estimation of allele frequencies and haplotypes
was performed with the Gene Hunter program.
Genotypes were tested for HWE using the exact
test. The significance of differences in the allele and
genotype frequencies between the groups was
determined by the χ2 test. One way analysis of
variance performed via the Mann-Whitney test was
used to evaluate the possible influence of TNF
polymorphisms on the age at onset. The samples
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were stratified for genotypes at each locus.
Statistical analyses were performed using the
Statistical Package for the Social Sciences (SPSS,
version 11.0). Value of p < 0.05 was considered
significant.
Results
In control and case populations, at the
polymorphic loci considered, the genotype counts
were in Hardy-Weinberg equilibrium, with non-
significant χ2 values. The genotype distribution and
allele frequencies of TNF gene polymorphisms are
shown in Table III. No significant differences were
found in the frequency of the genotype or allele
between patients and controls.
We assessed pairwise linkage disequilibrium (LD)
among SNPs in control subjects and we observed
strong LD among the polymorphisms TNF-857 and
TNF-1031, TNF-857 and TNF-α-308, TNF-857 and
TNF-β, TNF-1031 and TNF-β, TNF-α-308 and TNF-β,
TNF-1031 and TNF-238, TNF-376 and TNF-238 
(r2 = 0.1-0.28, D’ = 0.84-1, Table IV). 
The genotypes for the TNF resulted in five
possible haplotypes, the frequencies of which are
given in Table V. The haplotype distribution did not
differ between group A and group B. Further
haplotype analysis therefore did not give any
additional information to the analysis of the
individual SNPs. (The likelihood ratio test (LRT) for
the haplotype-phenotype association is not
statistically significant [χ2 = 0.72, df = 4, p = 0.949]).
The non-parametric analyses of variance perfor  -
med via Mann-Whitney test showed no significant
differences in the age at onset between genotype
groups and the six polymorphisms (Table VI). 
Comparison of genotype frequencies between
boys and girls in affected patients and control
individuals were not significantly different (Table VII). 
The presence of family history of migraine in
patients is shown in Figure 1. The distribution of
TNF polymorphisms was not associated with the
presence of family history of migraine in patients
(Table VIII).
Discussion
Our study demonstrates no significant
differences in the genotype distributions and allele
frequencies of TNF gene polymorphisms between
SNPs Primer name Primers
TNF-α: TNF_238F F 5’-AGAAGACCCCCCTCGGAACC-3’
–238G/A TNF_238_376R R 5’-GCTGGTCCTCTGCTGTCCTTG-3’
TNF-α: TNF-α-308F F 5’-AGGCAATAGGTTTTGAGGGCCAT-3’
–308G/A TNF-α-308R R 5’-TCCTCCCTGCTCCGATTCCG-3’
TNF-α:  TNF_376F F 5’-CAACCCCGTTTTCTCTCCCTC-3’
–376A/G TNF_238_376R R 5’-GCTGGTCCTCTGCTGTCCTTG-3’
TNF-α: TNF_1031_857_F F 5’-CAGGGGAAGCAAAGGAGAAG-3’
–857C/T TNF_1031_857_R R 5’-CCCTCTACATGGCCCTGTCTAC-3’
TNF-α:  TNF_1031_857_F F 5’-CAGGGGAAGCAAAGGAGAAG-3’
–1031T/C TNF_1031_857_R R 5’-CCCTCTACATGGCCCTGTCTAC-3’
TNF-β
TNF-B_F F 5’-GGTTTCCTTCTCTGTCTCTGACTCTCC-3’
TNF-B_R R 5’-GAGAGAGATCGACAGAGAAGGGGAC-3’
Table I. Primer sequences of all TNF polymorphisms 
SNPs Restriction enzyme PCR product [bp]                      Restriction enzyme digest fragment [bp]
Normal Mutant
TNF-α: –238G/A MspI 299 280 ±19 299
TNF-α: –308G/A NcoI 107 87 ±20 107
TNF-α: –376A/G Tsp509I 504 504 418 ±86
TNF-α: –857C/T HpyCH4IV 226 203 ±23 226
TNF-α: –1031T/C BbsI 226 226 194 ±32
TNF-β Nco I 173 102 ±71 173
Table II. The restriction enzyme, the PCR product and digest fragment (bp) after the action of the restriction enzyme
of all 6 polymorphisms
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patients with migraine without aura and healthy
controls. We report for the first time the
distributions of TNF alleles and genotypes in Greek
children affected by migraine without aura. Also,
we report for the first time the molecular analysis
of TNF-α-238, TNF-α-376, TNF-α-857 and TNF-α-1031
alleles in children affected by migraine.
Previous studies concerning the role of TNF gene
polymorphisms in migraine have provided
conflicting results and there has been no
confirmation of the role of TNF gene polymorphisms
as markers in migraine patients [10, 14, 16].
Our data for TNF-308G/A are in accordance with
the results of Trabace et al., as well as Asuni et al.
TNF Genotypes Alleles
Group AG roup BG roup AG roup B
n (%) n (%) n (%) n (%)
TNF-α-238
GG 96 (93.2) 170 (95.5) All 1 (G) 199 (96.6) 348 (97.8)
GA 7 (6.8) 8 (4.5) All 2 (A) 7 (3.4) 8 (2.2)
AA p = 0.419
p = 0.546 Exp(B) = 0.707
95% CI 0.230-2.180
TNF-α-308
GG 89 (86.4) 145 (81.5) All 1 (G) 192 (93.2) 321 (90.2)
GA 14 ( 13.6) 31 (17.4) All 2 (A) 14 (6.8) 35 (9.8) 
AA 0 (0) 2 (1.1) p = 0.281
p = 0.370 Exp(B) = 1.388
95% CI 0.678-2.840
TNF-α-376
GG 102 (99) 178 (100) All 1 (G) 205 (99.5) 356 (100)
GA 1 (1) 0 (0) All 2 (A) 1 (0.5)
AA p = 0.364
p = 1.000 Exp(B) = 0.000 
TNF-α-857
CC 64 (62.1) 113 (63.5) All 1 (C) 159 (77.2) 280 (78.7)
CT 31 (30.1) 54 (30.3) All 2 (T) 47 (22.8) 76 (21.3)
TT 8 (7.8) 11 (6.2) p = 0.754
p = 0.758 Exp(B) = 1.091
95% CI 0.627-1.900
TNF-α-1031
TT 66 (64.1) 110 (61.8) All 1 (T) 165 (80.1) 284 (79.8)
TC 33 (32) 64 (36) All 2 (C) 41 (19.9) 72 (20.2)
CC 4 (3.9) 4 (2.2) p = 1.000
p = 0.560 Exp(B) = 1.180
95% CI 0.677-2.057
TNF-β
GG 4 (3.9) 10 (5.6) All 1 (G) 39 (18.9) 77 (21.6)
GA 31 (30.1) 57 (32) All 2 (A) 167 (81.1) 279 (78.4)
AA 68 (66) 111 (62.4) p = 0.508
p = 0.640 Exp(B) = 0.741 
95% CI 0.211-2.603
Table III. Genotype distribution and allele frequencies of TNF gene polymorphisms in groups A and B
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[10, 12], but the same data are in discordance with
those of Rainero et al. and Mazaheri et al. [14, 16].
These two recent studies showed an increased risk
of migraine without aura associated with the 
TNF-α G308A polymorphism (Table IX).
Our data for TNF-β are in discordance with those
of Trabace et al., as well as Asuni et al., and
Martelleti et al. [10, 14, 15]. These three recent
studies showed an increased risk of migraine
without aura associated with the TNF-α G308A
polymorphism (Table IX). 
These discordant results may be explained
considering the significant differences among the
allele frequencies of TNF gene variants in
populations from different ethnic groups and
hypothesizing the same linkage disequilibrium with
the susceptibility genes of migraine without aura.
In particular, the TNF-α-308A allele is very rare in
Asians (A/G 16/84%) and Japanese (A/G 2/98%) [18].
Additionally, gene-gene, as well as gene-environment
interactions are likely, since migraine does not fit
a simple Mendelian pattern but is a “multifactorial
disease”. This could in part explain why
investigations of candidate susceptibility genes in
case control group studies as well as linkage analyses
16% 18%
45%
21%
Figure 1. Family history of migraine in group A
Father Mother Other None
TNF-238 TNF-308 TNF-376 TNF-857 TNF-1031 TNFB
TNF-238 1 1.00 0.02 1.00 0.95 1.00
TNF-308 0.00 1 0.11 1.00 0.59 0.84
TNF-376 0.00 0.00 1 0.27 0.25 0.28
TNF-857 0.01 0.03 0.00 1 0.91 1.00
TNF-1031 0.08 0.01 0.00 0.06 1 1.00
TNF-α 0.01 0.28 0.00 0.07 0.07 1
Table IV. Linkage disequilibrium coefficients (|D’|and |r2|) among TNF polymorphisms
SNPs Genotypes Age of onset of disease (group A)
TNF-238 GG 9.10 ±0.318
GA 10.00 ±1.528
p = 0.463
TNF-308 GG 9.31 ±0.342
GA + AA 8.33 ±0.667
p = 0.278
TNF-376 GG 9.17 ±0.318
GA
TNF-857 CC 9.08 ±0.392
CT + TT 9.31 ±0.522
p = 0.748
TNF-1031 TT 9.44 ±0.375
TC + CC 8.67 ±0.540
p = 0.234
TNF-β GG
GA + AA 9.15 ±0.317
Table VI. Correlation between genotypes and the age
of onset of the disease
Frequencies OR (95% CI)V alue of p
Group AG roup B
Ht1 G G G C T A 0.371 0.367
Ht2 G G G T T A 0.222 0.209 1.041 (0.658-1.645)  0.864
Ht3 G G G C C A 0.177 0.168 1.054 (0.626-1.776)  0.843
Ht4 G G G C T G 0.126 0.130 0.965 (0.550-1.691)  0.900
Ht5 G A G C T G 0.068 0.086 0.776 (0.370-1.627)  0.502
Table V. Association between different TNF haplotypes and migraine 
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SNPs Genotypes Group AG roup B
Boys Girls Boys Girls
TNF-238 GG 43 (39.2) 53 (53.8) 111 (62.4) 59 (33.1)
GA + AA 4 (4.1) 3 (2.9) 7 (3.9) 1 (0.6)
p = 0.171 Exp(B) = 0.395 95% CI 0.105-1.494
TNF-308 GG 41 (39.8) 48 (46.6) 97 (54.5) 48 (27.0)
GA + AA 5 (4.8) 9 (8.7) 21 (11.8) 12 (6.7)
p = 0.278 Exp(B) = 1.457 95% CI 0.738-2.875
TNF-376 GG 46 (44.7) 56 (54.4) 118 (66.3) 60 (33.7)
GA 0 (0.0) 1 (0.9)
p = 1.000 Exp(B) 6.7E+09
TNF-857 CC 29 (28) 35 (36.1) 74 (41.6) 40 (22.5)
CT + TT 16 (15.2) 21 (21.5) 44 (24.7) 20 (11.2)
p = 0.729 Exp(B) = 0.908 95% CI 0.528-1.563
TNF-1031 TT 26 (24.8) 38 (38.8) 69 (38.8) 41 (23.0)
TC + CC 19 (18.5) 18 (17.9) 49 (27.5) 19 (10.7)
p = 0.128 Exp(B) = 0.656 95% CI 0.382-1.129
TNF-β GG 3 (2.9) 1 (0.9) 7 (3.9) 3 (1.7)
GA + AA 42 (41.8) 55 (54.4) 111 (62.4) 57 (32.0)
p = 0.093 Exp(B) = 2.943 95% CI 0.835-10.371
Table VII. Correlation between genotypes and sex
SNPs Genotypes Positive family history of migraine
Father (%) Mother (%) Brother-sister (%)
TNF-238 GG 8.2 28.4 3
GA + AA 0.7 1.5 0
NS
TNF-308 GG 8.2 25.4 2.2
GA + AA 0.7 4.5 0.7
NS
TNF-376 GG 9 29.9 3.0
GA 0 0 0
NS
TNF-857 CC 7.5 14.9 0
CT + TT 1.5 14.9 3.0
NS
TNF-1031 TT 6.7 22.4 3
TC + CC 2.2 7.5 0
NS
TNF-β GG 10 3.0 0.7
GA + AA 8.9 26.9 2.2
NS
Table VIII. The distribution of TNF polymorphisms with the presence of family history of migraine in patients
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have at times shown variable results and attempts
at independent replication have failed [14, 18].
Additional analyses could focus on clinical
profiles, including symptoms, triggers, and
successful treatments, thus providing a more
comprehensive depiction of interactions between
the various components of the disorder [10, 14, 16].
The severity of migraine symptoms, such as the
recurrence and duration of attacks and the age at
onset of disease, are variable among patients, thus
rendering difficult the selection of the best
population in which to investigate the genetic load.
Complicating the issue is the likelihood that
many genetic variants may provide a modest yet
significant contribution to an individual’s migraine
susceptibility. Moreover, there might be a genetic
linkage between TNF polymorphisms and other
genes involved in the immune response that
increases the susceptibility of patients to
development of migraine without aura.
Nevertheless, due to the complex polygenic
nature of migraine, the search for migraine
susceptibility genes will remain challenging. Also,
the effective treatment options for migraine
sufferers are limited. Thus, with greater knowledge
of the genes and multiple gene profiles involved in
migraine susceptibility, future applications may
include individual genetic susceptibility profiling
and personally tailored pharmacogenetics in order
to abort attacks and control the disorder. 
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